Use of Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Supporting Shared Decision-Making Between Patients With Cancer and Clinicians
ACR Open Rheumatol
.
2023 Jun;5(6):305-307.
doi: 10.1002/acr2.11552.
Epub 2023 May 11.
Authors
Namrata Singh
1
,
Petros Grivas
2
,
Una E Makris
3
,
Maria E Suarez-Almazor
4
,
Ann M O'Hare
5
,
Jennifer L Barton
6
Affiliations
1
University of Washington, Seattle.
2
University of Washington and Fred Hutchinson Cancer Center, Seattle.
3
University of Texas Southwestern Medical Center, Dallas.
4
The University of Texas MD Anderson Cancer Center, Houston.
5
Department of Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle.
6
Oregon Health and Science University and Department of Veterans Affairs Portland Health Care System, Portland.
PMID:
37166652
PMCID:
PMC10267802
DOI:
10.1002/acr2.11552
No abstract available
Grants and funding
K23 AR079588/AR/NIAMS NIH HHS/United States
K23AR079588/AR/NIAMS NIH HHS/United States
K23AR079588/AR/NIAMS NIH HHS/United States